Houman D. Hemmati

Direktor/Vorstandsmitglied bei

Mediprint Ophthalmics, Inc.

Health Technology

Consumer Services

Finance

Profil

Houman D.
Hemmati is currently a Director at Noveome Biotherapeutics, Inc. and also holds Director positions at Trailhead Biosystems, Inc. and Mediprint Ophthalmics, Inc. Previously, he was an Advisor at Draper Fisher Jurvetson ePlanet Ventures, a Research Analyst at Griffen-Rose LLC, and a Vice President-Medical & Clinical Development at Capricor Therapeutics, Inc. Hemmati received his undergraduate degree from Stanford University and his doctorate degrees from the University of California, Los Angeles and the California Institute of Technology.

Aktive Positionen von Houman D. Hemmati

Unternehmen	Position	Beginn
Mediprint Ophthalmics, Inc. Mediprint Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary ocular drug-eluting contact lenses for eye care	Direktor/Vorstandsmitglied	-
Trailhead Biosystems, Inc. Trailhead Biosystems, Inc. BiotechnologyHealth Technology Develops cell based therapies	Direktor/Vorstandsmitglied	-
Noveome Biotherapeutics, Inc. Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines	Direktor/Vorstandsmitglied	16.11.2022

Alle aktiven Positionen von Houman D. Hemmati

Ehemalige bekannte Positionen von Houman D. Hemmati

Unternehmen	Position	Ende
Draper Fisher Jurvetson ePlanet Ventures Draper Fisher Jurvetson ePlanet Ventures Investment ManagersFinance DFJ ePlanet seeks to provide superior returns through investments in early-stage information technology and medical device start-ups in Asia and Europe, and in expansion-stage information technology and medical device companies in the US. The firm’s investments are focused primarily on wireless, semiconductor, consumer Internet, life sciences, VoIP, broadband and other emerging services sectors.	Corporate Officer/Principal	-
CAPRICOR THERAPEUTICS, INC.	Corporate Officer/Principal	-
Griffen-Rose LLC Griffen-Rose LLC Investment ManagersFinance Provides investment research	Analyst-Equity	-

Sehen Sie sich die Erfahrung von Houman D. Hemmati im Detail an

Ausbildung von Houman D. Hemmati

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Houman D. Hemmati im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	9
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Draper Fisher Jurvetson ePlanet Ventures Draper Fisher Jurvetson ePlanet Ventures Investment ManagersFinance DFJ ePlanet seeks to provide superior returns through investments in early-stage information technology and medical device start-ups in Asia and Europe, and in expansion-stage information technology and medical device companies in the US. The firm’s investments are focused primarily on wireless, semiconductor, consumer Internet, life sciences, VoIP, broadband and other emerging services sectors.	Finance
Griffen-Rose LLC Griffen-Rose LLC Investment ManagersFinance Provides investment research	Finance
Noveome Biotherapeutics, Inc. Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines	Health Technology
Capricor Therapeutics, Inc. Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases	Health Technology
Trailhead Biosystems, Inc. Trailhead Biosystems, Inc. BiotechnologyHealth Technology Develops cell based therapies	Health Technology
Mediprint Ophthalmics, Inc. Mediprint Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary ocular drug-eluting contact lenses for eye care	Health Technology